About t+ Medical

t+ Medical: Our partners

t+Medical's philosophy is to develop exceptional levels of product service by creating partnerships with well established sector leaders. Through total integration with its partners, t+Medical are able to provide innovative systems and technology that enhances quality of life. One of our key partners is J&J LifeScan with whom we work closely and have a collaboration agreement in place to develop leading edge products for the diabetes arena.

Academic Excellence

t+Medical have a close relationship with Oxford University. The Neural Network and Signal Processing group is a recognised centre of excellence in the field of medical signal processing with over 20 years of experience. Through this relationship t+Medical benefits not only from the opportunity to develop further intellectual property but also by working very closely with leading clinicians who have a track record of developing innovative solutions using both academic and commercial in put.                               

Commercial Partners

In addition to our close collaboration with LifeScan t+Medical have developed excellent commercial links with some of the UK's leading network providers. Theses relationships are essential for t+Medical's systems to be made widely available on speedy and reliable networks. t+Medical have been able to secure almost continuous funding from a number of network's Corporate Responsibility teams

We work with SFR in France on strategic development projects including clinical trials in Insulin Titration.

The Vodafone Group Foundation has provided support in the development of system trials in oncology and diabetes.

O2 has been involved in system trials in three different area's - asthma, cystic fibrosis and COPD at Bristol Royal Infirmary.

Manx Telecom supported a field trial of the t+Medical asthma product on the Isle of Man. Manx Telecom is the sole provider of both fixed line and mobile services on the Isle of Man and is a wholly owned subsidiary of O2.